Lopinavir/ritonavir population pharmacokinetics in neonates and infants.
about
The last and first frontier--emerging challenges for HIV treatment and prevention in the first week of life with emphasis on premature and low birth weight infants.Getting to 90-90-90 in paediatric HIV: What is needed?Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescentsPredicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling.Population pharmacokinetics of nefopam in elderly, with or without renal impairment, and its link to treatment response.Clindamycin Pharmacokinetics and Safety in Preterm and Term InfantsBritish HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review).Developments in early diagnosis and therapy of HIV infection in newborns.Prevention and treatment of HIV infection in neonates: evidence base for existing WHO dosing recommendations and implementation considerations.Pharmacokinetics and drug-drug interactions of lopinavir/ritonavir administered with first and second-line antituberculosis drugs in HIV-infected children treated for multidrug-resistant tuberculosis.Antiretroviral therapy during the neonatal period.British HIV Association guidelines for the management of HIV infection in pregnant women 2012
P2860
Q30382184-95991A28-2E72-4B2F-BFC0-6EBC362E1797Q30385352-F5871B8B-FA97-4165-B590-662A721B8E6AQ30832465-FF09B24C-D4B3-4DBC-832B-3502089E74BCQ30938796-6695B419-8642-40E6-B2AF-492CF80F0450Q33887993-2EB2C06D-B8F9-4759-8CB2-8FE4EF9E603EQ36887756-7BAA606F-A037-47EA-9BA7-34131FA7B5C5Q38325427-7C548F8F-5EAA-48E3-9454-87650BAC5AE5Q38648601-510AAA12-281A-42F3-AF91-54C42684415DQ45932455-8A2983D8-7029-4CCB-9639-469A8B8B42A0Q46895816-24A48ED4-33FC-4A58-9B59-C2BFC7B6347AQ53801515-9FC496AF-5C27-4280-A11F-957C432A3403Q57076282-9DB3B09E-7A28-48C6-AD8A-A7240638CCC6
P2860
Lopinavir/ritonavir population pharmacokinetics in neonates and infants.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Lopinavir/ritonavir population pharmacokinetics in neonates and infants.
@ast
Lopinavir/ritonavir population pharmacokinetics in neonates and infants.
@en
Lopinavir/ritonavir population pharmacokinetics in neonates and infants.
@nl
type
label
Lopinavir/ritonavir population pharmacokinetics in neonates and infants.
@ast
Lopinavir/ritonavir population pharmacokinetics in neonates and infants.
@en
Lopinavir/ritonavir population pharmacokinetics in neonates and infants.
@nl
prefLabel
Lopinavir/ritonavir population pharmacokinetics in neonates and infants.
@ast
Lopinavir/ritonavir population pharmacokinetics in neonates and infants.
@en
Lopinavir/ritonavir population pharmacokinetics in neonates and infants.
@nl
P2093
P2860
P50
P1476
Lopinavir/ritonavir population pharmacokinetics in neonates and infants.
@en
P2093
Albert Faye
Carole Giraud
Caroline Solas
Deborah Hirt
Ghislaine Firtion
Hermione Lyall
Isabelle Thuret
Jean-Marc Tréluyer
Marthe Leprevost
Saik Urien
P2860
P304
P356
10.1111/J.1365-2125.2011.03926.X
P407
P577
2011-06-01T00:00:00Z